Navigation Links
Isis Pharmaceuticals to Present at the 10th Annual Needham Healthcare Conference
Date:3/30/2011

CARLSBAD, Calif., March 30, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at Needham's 10th Annual Healthcare Conference on Wednesday, April 06, 2011 at 10:40 a.m. ET at the New York Palace Hotel.

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com.  A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners.  The Company has successfully commercialized the world's first antisense drug and has 24 drugs in development.  Isis' drug development programs are focused on treating cardiovascular, metabolic, and severe neurodegenerative diseases and cancer.  Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases.  Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics.  Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing.  As an innovator in RNA-based drug discovery and development, Isis has designed and executed a patent strategy that has provided the Company with strong and extensive protection for Isis' drugs and technology.  Additional information about Isis is available at www.isispharm.com.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , Oct. 1, 2014  SI-BONE, Inc., a medical ... System, ® a minimally invasive surgical (MIS) device indicated ... today announced the expansion of its European operations with the ... Eric Schaber as General Manager, Germany.  Mr. Schaber will ... president of Europe , Middle ...
(Date:9/30/2014)... 30, 2014 /CNW/ - Protecting the health and safety of Canadians ... uses the appropriate powers and tools at its disposal to help ... quality standards. To that end, Health ... import into Canada of all drug products ... are: , Apotex Pharmachem India Pvt Ltd ...
(Date:9/30/2014)... Md. , Sept. 30, 2014  Tasly ... way to modernize medicine, announced today the launch ... of nutraceuticals developed to address men and women ... healthy and vibrant into old age while helping ... includes three condition-specific, whole-food and herb-based formulas, namely, ...
Breaking Medicine Technology:SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 2SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 3SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 4Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2
... 17 An optimized PARI eFlow,platform nebulizer will ... clinical trial that has begun enrolling patients. ALN-RSV01 ... for respiratory syncytial virus,(RSV) infection, the leading cause ... infection in immune-compromised adults. RSV currently does,not have ...
... 17 AlphaVax, Inc.,announced today an initial analysis ... a cytomegalovirus (CMV) vaccine that is based on ... is a placebo-controlled, randomized, double-blind, single,center study involving ... is being conducted by David I. Bernstein, M.D., ...
Cached Medicine Technology:PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study 2AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial 2AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial 3
(Date:10/1/2014)... Insuranceragents.info has released a new blog post ... for vulnerable family members. , Life insurance plans provide ... the family should always carry a life insurance policy ... rest of the family. , Clients can choose ... from temporary coverage or from a permanent policy. No ...
(Date:10/1/2014)... and ATLANTA (PRWEB) October 01, 2014 ... security executive networking and relationship-marketing firm, announced ... Information Security Executive® and Project of the ... top-ranking decision makers representing organizations in financial ... Projects include large-scale technology endeavors that address ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Between 23 ... in the U.S., according to figures from the National ... Diseases Association (AARDA), and many of them have something ... of having undiagnosed celiac disease. Gluten Free Therapeutics, ... awareness of undiagnosed celiac disease by publishing a series ...
(Date:10/1/2014)... 01, 2014 Scientists at the University ... that target immune system proteins has the power to ... posted details of the new study on their website. ... , Researchers in the UWA School of Pathology and ... to mice with mesothelioma with promising results. , ...
(Date:10/1/2014)... 01, 2014 Woodland Hills dental ... a group of dental specialists who treat full mouth ... city of Oviedo. Dr. Reshad of the Anacapa Dental ... clients on two continents, will give a full-day presentation ... mouth reconstruction. , “These specialists want to improve their ...
Breaking Medicine News(10 mins):Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 3Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 4
... that often deals with changes over many generations have ... A lot, some scientists say. If recent recommendations are implemented, ... entrance and licensing exams, says an international group of doctors ... 26 issue of Proceedings of the National Academy of ...
... is the focus of a $1.27-million grant from the ... researchers working with employees from six Pennsylvania prisons and ... an intervention toolkit for use by staff at any ... to optimize the quality of life for dying patients ...
... Vancouver’s ... meet Matt Lauer when he is in Vancouver to shoot the Today Show during the ... (PRWEB) ... is on a mission to meet Matt Lauer when he is in Vancouver to shoot ...
... , ... Spend More Time Indoors Increasing Owners Exposure to Allergens Like Pet Dander. earthbath’s Totally Natural ... , ... 26, 2010 -- Everyone wants to be inside when winter’s chilly winds blow, and Fido ...
... ... for physicians, including current and future adoption of electronic medical records, e-prescribing, ... ... are the physician specialist groups most likely to communicate with patients online, according ...
... SEATTLE , Jan. 26 Milliman Care Guidelines ... tools that help health plans, hospitals and other clients optimize ... and software.   , The Care Guidelines promote ... based on annually updated evidence, thus enabling informed and consistent ...
Cached Medicine News:Health News:Medical students may soon be tested on evolution 2Health News:Medical students may soon be tested on evolution 3Health News:End-of-life care strategies examined in Pennsylvania prisons 2Health News:Vancouver Company Must Meet Matt Lauer During Olympics 2Health News:Control Winter Pet Dander with earthbath's New Waterless Grooming Foam for Dogs 2Health News:Control Winter Pet Dander with earthbath's New Waterless Grooming Foam for Dogs 3Health News:Dermatologists, Medical Oncologists are the Top Physician Specialist Groups Communicating with Patients Online 2Health News:Dermatologists, Medical Oncologists are the Top Physician Specialist Groups Communicating with Patients Online 3Health News:Dermatologists, Medical Oncologists are the Top Physician Specialist Groups Communicating with Patients Online 4Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 2Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 3Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: